查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1905702

日本心血管器材市场规模、份额、趋势及预测（按器材类型、应用、最终用户和地区划分），2026-2034年

Japan Cardiovascular Devices Market Size, Share, Trends and Forecast by Device Type, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本心血管器材市场规模达360万美元。展望未来， IMARC Group预计到2034年，该市场规模将达到710万美元，2026年至2034年间的复合年增长率（CAGR）为8.00%。人口老化、心血管疾病发生率上升以及技术进步是推动市场成长的主要因素。主要细分市场包括心臟节律器、支架和监测设备。政府措施和不断增加的医疗保健投资促进了市场成长，而监管政策则影响产品的审批和应用。

本报告解答的关键问题：

  • 日本心血管器材市场目前的表现如何？未来几年又将如何发展？
  • 日本心血管器材市场按器材类型分類的组成是怎样的？
  • 日本心血管器材市场按应用领域分類的组成是怎样的？
  • 日本心血管器材市场依最终用户分類的组成是怎样的？
  • 日本心血管器材市场价值链的各个阶段有哪些？
  • 日本心血管器械产业的关键驱动因素和挑战是什么？
  • 日本心血管器材市场的结构是怎么样的？主要参与者有哪些？
  • 日本心血管器材市场的竞争程度如何？

目录

第一章：序言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 数据来源
  • 市场估算
  • 预测方法

第三章：执行概要

第四章：日本心血管器材市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本心血管器材市场概况

  • 历史及当前市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本心血管器材市场－依器械类型划分

  • 诊断和监测设备
  • 治疗及外科器械

第七章：日本心血管器材市场－依应用领域划分

  • 冠状动脉疾病（CAD）
  • 心律不整
  • 心臟衰竭
  • 其他的

第八章：日本心血管器材市场－以最终用户划分

  • 医院
  • 专科诊所
  • 其他的

第九章：日本心血管器材市场－按地区划分

  • 关东地区
  • 关西/近畿地区
  • 中部/中部地区
  • 九州·冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本心血管器材市场－竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争格局分析
  • 公司评估象限

第十一章：关键参与者简介

第十二章：日本心血管器材市场－产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章：附录

简介目录
Product Code: SR112026A32512

The Japan cardiovascular devices market size reached USD 3.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 7.1 Million by 2034, exhibiting a growth rate (CAGR) of 8.00% during 2026-2034. The market is driven by an aging population, rising cardiovascular diseases, and technological advancements. Key segments include pacemakers, stents, and monitoring devices. Government initiatives and increasing healthcare investments support market growth, while regulatory policies influence product approvals and adoption.

Japan Cardiovascular Devices Market Trends:

Rising Demand for Minimally Invasive Cardiovascular Procedures

Japan is facing a higher demand for minimally invasive (MI) cardiovascular devices owing to an aging population and improved catheter-based treatments. The adoption of transcatheter aortic valve replacement (TAVR) and percutaneous coronary interventions (PCI) is rising, reducing hospital stays and accelerating recovery. Japanese medical device companies are investing in robotics-assisted procedures and next-generation catheters to improve precision. The regulatory environment, under the guidance of the Pharmaceuticals and Medical Devices Agency (PMDA), is making approval easier for groundbreaking technologies, permitting quicker market entry. Furthermore, artificial intelligence (AI) is improving the precision of cardiovascular imaging diagnostics, aiding early intervention protocols. For example, in September 2024, Japan-based Cardio Intelligence introduced SmartRobin AI, an ECG monitoring system powered by explainable AI for fast atrial fibrillation detection, enhancing stroke risk assessment and diagnostic accuracy in cardiovascular care. Additionally, with home healthcare being supported by the government, remote monitoring devices such as wearable ECGs and implantable loop recorders are also becoming popular. The trend is in support of Japan's value-based medicine drive, stressing cost-effectiveness and patient outcome. With shifting reimbursement policies, the market can anticipate increased growth in minimally invasive cardiovascular solutions.

Growth of AI-Integrated Cardiovascular Diagnostics

AI is transforming cardiovascular diagnostics in Japan, improving early disease detection and predictive analytics. AI-driven echocardiography and computed tomography (CT) imaging machines are enabling faster, more accurate diagnosis of heart disease. Large research centers and hospitals are applying AI in real-time monitoring of the heart, reducing the burden on healthcare personnel. ML technologies are being integrated into electronic health records (EHRs) for predicting risks of heart failure, allowing preventive treatment modalities. The focus on digital health innovation in Japan is inducing collaborations between medtech firms and AI startups to accelerate the deployment of intelligent diagnostic equipment. The government drive in personalized medicine is also driving AI-enabled cardiovascular care so that precise treatment plans are delivered based on gene and lifestyle factors. As AI reduces diagnostic errors and increases workflow efficiency, its use in cardiovascular devices is increasing, leading to improved patient management and long-term healthcare cost savings. For instance, in September 2024, Olympus launched VISERA S, an all-in-one imaging platform with NBI and stroboscopy, across Europe, Asia, and Oceania, enhancing ENT diagnostics with improved visualization and streamlined workflow.

Expansion of Wearable and Remote Cardiac Monitoring Devices

Wearable and remote cardiac monitoring devices are gaining quick adoption in Japan, fueled by the increasing age population and the rising incidence of heart diseases. Smartwatches with built-in ECG, hand-carried Holter monitors, and implantable cardiac event recorders are becoming cornerstones of preventive cardiology. The emergence of 5G connectivity is accelerating real-time data transmission, allowing doctors to monitor patients remotely and catch anomalies before critical events. Japanese device makers are creating small, easy-to-use wearables with longer battery life to drive patient compliance. PMDA support is driving speedy approvals of cutting-edge telemedicine solutions as the nation accelerates healthcare digitalization. Insurers are starting to reimburse for remote monitoring services, further driving market expansion. As clinics and hospitals implement cloud-based cardiac monitoring systems, data-driven information is maximizing treatment plans, lowering hospital readmissions, and enhancing patient outcomes in Japan's changing cardiovascular care environment.

Japan Cardiovascular Devices Market Segmentation:

Device Type Insights:

  • Diagnostic and Monitoring Devices
    • Electrocardiogram (ECG)
    • Remote Cardiac Monitoring
    • Others
  • Therapeutic and Surgical Devices
    • Cardiac Rhythm Management (CRM) Devices
    • Catheter
    • Stents
    • Heart Valves
    • Others

Application Insights:

  • Coronary Artery Disease (CAD)
  • Cardiac Arrhythmia
  • Heart Failure
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Others

Region Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan cardiovascular devices market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan cardiovascular devices market on the basis of device type?
  • What is the breakup of the Japan cardiovascular devices market on the basis of application?
  • What is the breakup of the Japan cardiovascular devices market on the basis of end user?
  • What are the various stages in the value chain of the Japan cardiovascular devices market?
  • What are the key driving factors and challenges in the Japan cardiovascular devices?
  • What is the structure of the Japan cardiovascular devices market and who are the key players?
  • What is the degree of competition in the Japan cardiovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cardiovascular Devices Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Cardiovascular Devices Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Cardiovascular Devices Market - Breakup by Device Type

  • 6.1 Diagnostic and Monitoring Devices
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Electrocardiogram (ECG)
      • 6.1.3.2 Remote Cardiac Monitoring
      • 6.1.3.3 Others
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Therapeutic and Surgical Devices
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Cardiac Rhythm Management (CRM) Devices
      • 6.2.3.2 Catheter
      • 6.2.3.3 Stents
      • 6.2.3.4 Heart Valves
      • 6.2.3.5 Others
    • 6.2.4 Market Forecast (2026-2034)

7 Japan Cardiovascular Devices Market - Breakup by Application

  • 7.1 Coronary Artery Disease (CAD)
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Cardiac Arrhythmia
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Heart Failure
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Others
    • 7.4.1 Historical and Current Market Trends (2020-2025)
    • 7.4.2 Market Forecast (2026-2034)

8 Japan Cardiovascular Devices Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Specialty Clinics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Others
    • 8.3.1 Historical and Current Market Trends (2020-2025)
    • 8.3.2 Market Forecast (2026-2034)

9 Japan Cardiovascular Devices Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Device Type
    • 9.1.4 Market Breakup by Application
    • 9.1.5 Market Breakup by End User
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Device Type
    • 9.2.4 Market Breakup by Application
    • 9.2.5 Market Breakup by End User
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Device Type
    • 9.3.4 Market Breakup by Application
    • 9.3.5 Market Breakup by End User
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Device Type
    • 9.4.4 Market Breakup by Application
    • 9.4.5 Market Breakup by End User
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Device Type
    • 9.5.4 Market Breakup by Application
    • 9.5.5 Market Breakup by End User
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Device Type
    • 9.6.4 Market Breakup by Application
    • 9.6.5 Market Breakup by End User
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Device Type
    • 9.7.4 Market Breakup by Application
    • 9.7.5 Market Breakup by End User
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Device Type
    • 9.8.4 Market Breakup by Application
    • 9.8.5 Market Breakup by End User
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Cardiovascular Devices Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Services Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Services Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Services Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Services Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Services Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Cardiovascular Devices Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix